Aino Health AB (AINO) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Net Sales has grown by an annual rate of 0.53% over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -11.07

Risky -

Mojo Parameters

Stock DNA

Industry

Miscellaneous

Market cap

SEK 36 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.01

Return on Equity

209.62%

Price to Book

-12.75

Revenue and Profits:

Net Sales:

7 Million

(Quarterly Results - Jun 2025)

Net Profit:

-1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-12.86%

6 Months

-25.61%

1 Year

31.18%

2 Years

-39.38%

3 Years

-82.65%

4 Years

-60.65%

5 Years

-80.19%

Aino Health AB for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

0.53%

EBIT Growth (5y)

10.95%

EBIT to Interest (avg)

-11.07

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

1.08

Sales to Capital Employed (avg)

-10.46

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-22.77

EV to EBIT

-6.56

EV to EBITDA

-14.84

EV to Capital Employed

-22.81

EV to Sales

1.31

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

Negative BV

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Sideways

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

No Trend

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 1.35% vs 23.33% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.00% vs 82.86% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.50",
          "val2": "7.40",
          "chgp": "1.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.40",
          "val2": "0.30",
          "chgp": "33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.10",
          "chgp": "100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.60",
          "val2": "-0.60",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-45.00%",
          "val2": "-56.90%",
          "chgp": "1.19%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 20.10% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 7.48% vs 28.67% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "23.90",
          "val2": "23.90",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-7.10",
          "val2": "-7.30",
          "chgp": "2.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "1.10",
          "chgp": "-27.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-9.90",
          "val2": "-10.70",
          "chgp": "7.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-382.60%",
          "val2": "-390.40%",
          "chgp": "0.78%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

7.50

7.40

1.35%

Operating Profit (PBDIT) excl Other Income

0.40

0.30

33.33%

Interest

0.20

0.10

100.00%

Exceptional Items

0.00

Consolidate Net Profit

-0.60

Operating Profit Margin (Excl OI)

-45.00%

-56.90%

1.19%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 1.35% vs 23.33% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 82.86% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

23.90

Operating Profit (PBDIT) excl Other Income

-7.10

-7.30

2.74%

Interest

0.80

1.10

-27.27%

Exceptional Items

0.00

Consolidate Net Profit

-9.90

-10.70

7.48%

Operating Profit Margin (Excl OI)

-382.60%

-390.40%

0.78%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 20.10% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 7.48% vs 28.67% in Dec 2023

All Annual Results

Company CV

About Aino Health AB

Aino Health AB

Miscellaneous

Aino Health AB (publ) is a Sweden-based company, which is primarily engaged in the health management industry. The Company operates as a provider of corporate health management (CHM) solutions. The Company's Aino HealthManager solution allows organizations to monitor their personnel’s working capacity and the impact of different measures. The Company's Aino SafetyManager platform provides safety management tools. The Company's Aino HealthDesk solution is a multichannel service designed for employee's sick leave related issues. Its TeleHealth solution offers remote occupational health care visits. In addition, the Company provides various services, such as business process outsourcing and health management consulting services, among others.

Company Coordinates

Company Details

Skeppargatan 8 , STOCKHOLM None : 114 52

Tel:

https://ainohealth.com/

Registrar Details